Study reveals COVID-19 stress linked to increased substance use during pregnancy
Stress-driven substance use patterns during pregnancy have increased amid COVID-19 stress. This research highlights risks to maternal and fetal health. Understanding these patterns aids clinical care during public health crises.
A New Take on the Antidepressants vs Psychedelics Efficacy Debate – Drug Science
This article explores psychedelic therapies for depression, focusing on their efficacy compared to traditional antidepressants. It highlights the clinical complexity in comparing these treatments for patients with treatment-resistant depression.…
Cannabis and Psychosis: Risks of High-THC Frequent Use
High-potency cannabis linked to mental health risks is a critical concern, particularly for adolescents. Frequent use of high-THC products increases the risk of psychotic episodes. Understanding these risks helps clinicians provide better care and…
New Study Questions Cannabis for Anxiety and Depression
This article reviews clinical evidence cannabis anxiety depression to assess medical marijuana's role in treatment. The study challenges assumptions about cannabis benefits for anxiety and depression. Clinicians require evidence-based guidance for…
New Study Questions Medical Cannabis for Anxiety and Depression
This medical cannabis anxiety relief study examines the effects of cannabis on anxiety and depression. The findings highlight the need for evidence-based guidance in clinical settings. Clinicians should consider this study when advising patients on…
The media said there’s “no evidence” medical cannabis helps anxiety, depression or PTSD …
Media misinterpretation clinical evidence creates confusion about medical cannabis benefits for anxiety, depression, and PTSD. Emerging studies suggest potential therapeutic effects despite limited FDA approval. Clinicians must understand evidence…
Sparse Evidence For Cannabis To Treat Mental Health Conditions Highlights Research Gap
Mental health research gap remains a critical issue in cannabis treatment evidence. Current studies show limited data for cannabis use in anxiety, PTSD, and depression. Clinicians must navigate this gap carefully when advising patients.
What This Lancet Review Really Says About Cannabinoids in Psychiatry – CED Clinic
The cannabinoids mental health evidence from The Lancet review highlights mixed quality research with some promising findings. This review influences clinical guidelines and provider perspectives on cannabis therapeutics in psychiatry. Understanding this…
New Research Challenges Cannabis Use for Mental Health Treatment
New research cannabis mental health treatment findings highlight challenges in current clinical approaches. Evidence-based evaluation remains essential for safe use. Clinicians must consider rigorous data before changing treatment protocols.
Cannabinoids for Mental Health: Large Review Finds Mostly Low-Quality Evidence With …
This cannabinoids mental health systematic review highlights the predominance of low-quality evidence in cannabis-based mental health treatments. It underscores the gap between patient demand and robust clinical data. Clinicians should counsel patients…